Related Experiment Video
Updated: Aug 28, 2025

07:51
Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
150
Cannabis dosing and administration for sleep: a systematic review
Rob Velzeboer1, Adeeb Malas2, Pierre Boerkoel3
1Clinical Research, Tranq Sleep Care , Kelowna, British Columbia, Canada.
Sleep
|September 15, 2022
Summary
Cannabis shows some promise for improving sleep, particularly for pain-related disorders. However, high-quality evidence is limited, and specific dosing recommendations for cannabis and sleep are not yet established.
Area of Science:
- Pharmacology
- Sleep Medicine
- Cannabis Research
Background:
- Increasing use of cannabis for sleep disorders.
- Need for evidence-based guidance for prescribers.
- Focus on cannabis dosing for sleep.
Approach:
- A comprehensive search of EMBASE, Medline, and Web of Science was conducted.
- 31 studies were included for analysis, with bias assessed using the Cochrane Risk of Bias tool 2.0.
Key Points:
- Cannabis demonstrated improvements in subjective sleep quality for some participants, especially those with pain-related disorders.
- No significant differences were found between tetrahydrocannabinol and cannabidiol effects on sleep.
- Adverse events like sedation and dizziness were dose-dependent, with no serious events reported.
Conclusions:
- Limited high-quality evidence supports cannabis for sleep.
- Heterogeneity in cannabis products and study designs hinders dosing recommendations.
- Further research needed to establish optimal cannabis use for sleep.
Related Concept Videos
Substance Use Disorders Affecting Sleep
211
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
211
Sedatives and Hypnotics: Overview
592
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
592
Sedatives and Hypnotics Drugs: Miscellaneous Agents
231
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
231
Management of Insomnia
313
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
313
CNS Depressants: Barbiturates and Benzodiazepines
439
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
439
Drug Dosage Regimen: Overview
3.7K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.7K

